A randomised placebo-controlled trial of epirubicin and quinidine in patients with advanced breast cancer
Completed
- Conditions
- BreastCancer
- Registration Number
- ISRCTN23196537
- Lead Sponsor
- Cancer Research UK (CRUK) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Histologically proven metastatic or locally advanced disease
2. Measurable or evaluable disease
3. World Health Organisation (WHO) Performance status at least 2
4. Haemoglobin =10 g%
5. White Blood Count (WBC) >4.0 x10^9/l
6. Platelets =100 x 10^9/l
7. Bilirubin within normal range
8. Not currently receiving hormone treatment
9. No prior chemotherapy for advanced disease
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration